corporate_fare
Tessera Therapeutics Inc.
- Address
- 101 South Street Suite 500
Sponsor Overview
assignment
1
sponsored trial
science
0
molecules
location_city
4
research centres
public
3
countries
person_search
4
investigators
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 1/2 Open‑Label Multi‑Center Dose‑Escalation and Expansion Study of Intravenous TSRA‑196 in Adults with PiZZ‑Genotype Alpha‑1 Antitrypsin Deficiency‑Related Lung and/or Liver Disease |  Ireland Sweden The Netherlands | Not Yet Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 4 sites collaborated multiple times
This sponsor has worked with 4 sites across their trial portfolio.
Therapeutic Focus
- 1.Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial165 other sponsors
- 2.Nutritional and Metabolic Diseases1 trial211 other sponsors
- 3.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
4 centreslocation_city
assignment139Beaumont Hospital
- Address
- Beaumont Road, Beaumont, D09 V2N0 Dublin
location_city
assignment590Karolinska University Hospital
- Address
- Eugeniavagen 3, 171 64 Solna
location_city
assignment323Leids Universitair Medisch Centrum (LUMC)
- Address
- Albinusdreef 2, 2333 ZA Leiden
location_city
assignment331Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen
- Address
- Behandlingsvagen 7, Harlanda, 416 50 Gothenburg
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Tessera Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.